Atopic Dermatitis: September 2019

Ameriderm Research announce a new clinical trial is for patients aged 12 to 17 with moderate to severe atopic dermatitis that will be starting September 2019. It involves administering oral medication co-administered with topical therapy as a double-blind, randomized, placebo treatments controlled for 12 weeks of treatment and 1 month follow-up

The trial is expected to enroll quickly. To see if you qualify please call (386) 523-0768 today.

Join Clinical Trial

Posted in

Ameriderm Research